1. Home
  2. CADL vs LTBR Comparison

CADL vs LTBR Comparison

Compare CADL & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.83

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$10.99

Market Cap

575.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
LTBR
Founded
1999
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
578.8M
575.6M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
CADL
LTBR
Price
$8.83
$10.99
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
2.2M
843.2K
Earning Date
05-14-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$9.78
52 Week High
$9.27
$31.34

Technical Indicators

Market Signals
Indicator
CADL
LTBR
Relative Strength Index (RSI) 68.29 43.42
Support Level $4.80 $10.00
Resistance Level $9.27 $11.53
Average True Range (ATR) 0.60 0.78
MACD -0.04 -0.04
Stochastic Oscillator 75.28 27.18

Price Performance

Historical Comparison
CADL
LTBR

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

Share on Social Networks: